8/19/24 11:08 | 8/15/24 | MLAB | Mesa Laboratories Inc /co/ | CO | Electr | LabEq | Industrial Instruments For Me | Capone Mark Christopher | UT | D | | M.d | 0 | 0.00 | 0 | 1 | New | 1 | D | | | | | | | | | | | | | | |
8/2/19 17:45 | 8/1/19 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,C.E.O. | M.d | 3,614 | 26.38 | 0 | 137 | 45 | 441 | D | | | | | | | | | | | | | | |
8/2/19 17:45 | 8/1/19 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,C.E.O. | S.d | -6,028 | 44.00 | 0 | -137 | -24 | 441 | D | | | | | | | | | | | | | | |
6/1/18 17:43 | 5/30/18 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,C.E.O. | M.d | 2,064 | 22.93 | 0 | 90 | 37 | 332 | D | | | | | | | | | | | | | | |
6/1/18 17:43 | 5/30/18 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,C.E.O. | S.d | -3,420 | 38.00 | 0 | -90 | -21 | 332 | D | | | | | | | | | | | | | | |
8/19/16 11:41 | 8/19/16 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,C.E.O. | P | 212 | 21.24 | 33 | 10 | 7 | 146 | D | -43 | -38 | -39 | -37 | -33 | -31 | -28 | -1 | 0 | -3 | -2 | -21 | -12 | |
2/25/14 18:13 | 2/25/14 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | M.d | 1,809 | 18.99 | 33 | 95 | | 48 | D | 63 | 52 | 35 | 35 | 61 | 39 | 24 | 11 | -1 | -2 | -9 | -12 | -3 | -10 |
2/25/14 18:13 | 2/25/14 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | S.d | -3,603 | 37.83 | 33 | -95 | -66 | 48 | D | 63 | 52 | 35 | 35 | 61 | 39 | 24 | 11 | -1 | -2 | -9 | -12 | -3 | -10 |
2/10/14 18:08 | 2/10/14 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | M.d | 1,538 | 17.58 | 33 | 88 | | 48 | D | 34 | 24 | 7 | 27 | 33 | 29 | 17 | 19 | -3 | -2 | 8 | 12 | 18 | 3 |
2/10/14 18:08 | 2/10/14 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | S.d | -2,806 | 32.07 | 33 | -88 | -64 | 48 | D | 34 | 24 | 7 | 27 | 33 | 29 | 17 | 19 | -3 | -2 | 8 | 12 | 18 | 3 |
5/17/13 17:21 | 5/16/13 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | M.d | 1,414 | 17.68 | 33 | 80 | | 48 | D | 37 | 28 | 10 | 37 | 35 | 21 | 17 | 0 | 0 | -2 | -19 | -16 | -19 | 12 |
5/17/13 17:21 | 5/16/13 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | S.d | -2,659 | 33.23 | 33 | -80 | -62 | 48 | D | 37 | 28 | 10 | 37 | 35 | 21 | 17 | 0 | 0 | -2 | -19 | -16 | -19 | 12 |
11/21/12 12:44 | 11/20/12 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | M.dm | 567 | 16.04 | 25 | 35 | 273 | 48 | D | 44 | 53 | 18 | 15 | 9 | 16 | 3 | 0 | -1 | -2 | -10 | -18 | 6 | -7 |
11/21/12 12:44 | 11/20/12 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | S.dm | -1,074 | 30.41 | 25 | -35 | -42 | 48 | D | 44 | 53 | 18 | 15 | 9 | 16 | 3 | 0 | -1 | -2 | -10 | -18 | 6 | -7 |
11/13/12 17:12 | 11/12/12 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | M.d | 826 | 13.28 | 20 | 62 | | 48 | D | 43 | 47 | 16 | 18 | 11 | 16 | 12 | 0 | -1 | 1 | -9 | -19 | 11 | -11 |
11/13/12 17:12 | 11/12/12 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | S.d | -1,860 | 29.91 | 20 | -62 | -56 | 48 | D | 43 | 47 | 16 | 18 | 11 | 16 | 12 | 0 | -1 | 1 | -9 | -19 | 11 | -11 |
11/8/12 16:08 | 11/6/12 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | M.d | 329 | 12.17 | 19 | 27 | 127 | 48 | D | 45 | 46 | 16 | 20 | 14 | 11 | 15 | 11 | 0 | 2 | -7 | -11 | 12 | -11 |
11/8/12 16:08 | 11/6/12 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | S.d | -776 | 28.75 | 19 | -27 | -36 | 48 | D | 45 | 46 | 16 | 20 | 14 | 11 | 15 | 11 | 0 | 2 | -7 | -11 | 12 | -11 |
9/12/12 16:54 | 9/10/12 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | M.d | 177 | 8.95 | 22 | 20 | 67 | 49 | D | 63 | 45 | 8 | 15 | 8 | 5 | 7 | 1 | 0 | 2 | 0 | 2 | -4 | -3 |
9/12/12 16:54 | 9/10/12 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | S.d | -535 | 27.00 | 22 | -20 | -29 | 49 | D | 63 | 45 | 8 | 15 | 8 | 5 | 7 | 1 | 0 | 2 | 0 | 2 | -4 | -3 |
5/4/12 16:30 | 5/2/12 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | M.d | 38 | 8.99 | 19 | 4 | 9 | 49 | D | 43 | 18 | 30 | 12 | 15 | 12 | 5 | 2 | 0 | -1 | -12 | -6 | 3 | 8 |
5/4/12 16:30 | 5/2/12 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | S.d | -115 | 27.00 | 19 | -4 | -8 | 49 | D | 43 | 18 | 30 | 12 | 15 | 12 | 5 | 2 | 0 | -1 | -12 | -6 | 3 | 8 |
7/14/10 11:11 | 7/12/10 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | M.d | 43 | 8.63 | 25 | 5 | 11 | 50 | D | -40 | -37 | -39 | -32 | -13 | -2 | 6 | -1 | 0 | -3 | -4 | 8 | 33 | 52 |
5/11/10 17:21 | 5/10/10 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | M.d | 25 | 9.04 | 33 | 3 | 7 | 45 | D | -3 | -35 | -26 | -17 | -28 | -21 | -25 | -3 | 2 | 4 | -2 | -15 | 15 | 29 |
2/19/10 16:07 | 2/18/10 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | COO,MGL | M.d | 54 | 7.66 | 33 | 7 | 20 | 42 | D | 26 | -44 | -13 | -7 | -20 | -3 | 0 | 1 | 0 | 1 | 13 | -17 | -27 | -13 |
7/14/09 15:35 | 7/13/09 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | COO,MGL | M.d | 109 | 7.27 | 33 | 15 | 73 | 35 | | | | | | | | | | 1 | 4 | 6 | 7 | 3 | -37 |
4/7/09 16:05 | 4/6/09 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | COO,MGL | M.d | 655 | 18.19 | 33 | 36 | | 20 | D | 143 | 113 | 41 | 21 | 6 | 5 | -4 | -4 | 4 | 4 | -25 | -36 | -32 | -41 |
4/7/09 16:05 | 4/6/09 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | COO,MGL | S.d | -1,550 | 43.07 | 33 | -36 | -64 | 20 | D | 143 | 113 | 41 | 21 | 6 | 5 | -4 | -4 | 4 | 4 | -25 | -36 | -32 | -41 |
2/24/09 18:12 | 2/23/09 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | COO,MGL | M.d | 110 | 15.28 | 33 | 7 | 241 | 10 | | | | | | | | | | -1 | -8 | -1 | -21 | -33 | -42 |
2/11/09 16:47 | 2/9/09 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | COO,MGL | S.d | -1,870 | 85.40 | 33 | -22 | -88 | 3 | | | | | | | | | | 1 | -1 | -4 | -24 | -32 | -45 |
2/11/09 16:47 | 2/9/09 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | COO,MGL | M.d | 464 | 29.35 | 33 | 16 | | 3 | | | | | | | | | | 1 | -1 | -4 | -24 | -32 | -45 |
9/11/08 16:13 | 9/9/08 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | COO,MGL | M.d | 46 | 15.28 | 33 | 3 | 49 | 9 | D | 171 | 40 | 83 | 43 | 2 | -1 | -5 | 2 | -1 | -3 | -13 | -6 | 25 | 3 |
9/3/08 17:07 | 8/29/08 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | COO,MGL | M.d | 342 | 18.98 | 33 | 18 | | 6 | D | 171 | 55 | 85 | 42 | 10 | 1 | 8 | 2 | -3 | -4 | -1 | -14 | 20 | 1 |
9/3/08 17:07 | 8/29/08 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | COO,MGL | S.d | -1,223 | 67.93 | 33 | -18 | -75 | 6 | D | 171 | 55 | 85 | 42 | 10 | 1 | 8 | 2 | -3 | -4 | -1 | -14 | 20 | 1 |
8/9/07 16:20 | 8/7/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | COO,MGL | M.d | 73 | 15.28 | 33 | 5 | 365 | 6 | D | 155 | 78 | 20 | 17 | 20 | 14 | 19 | 18 | -7 | -9 | 3 | 19 | -12 | 45 |
8/9/07 16:20 | 8/7/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | COO,MGL | S.d | -205 | 43.01 | 33 | -5 | -44 | 6 | D | 155 | 78 | 20 | 17 | 20 | 14 | 19 | 18 | -7 | -9 | 3 | 19 | -12 | 45 |
3/26/07 15:54 | 3/23/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | COO,MGL | M.d | 72 | 13.35 | 33 | 5 | 793 | 6 | D | 66 | 35 | 41 | 12 | -5 | 6 | 7 | 4 | 1 | -1 | 2 | 4 | 34 | 12 |